Ipca Laboratories informs about disclosure

31 Oct 2023 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company had vide its letter dated 23rd June, 2023, intimated about US FDA inspection of Company’s formulations manufacturing facility situated at SEZ Indore, Pithampur (Madhya Pradesh) from 15th June, 2023 to 23rd June, 2023. Ipca Laboratories has informed that this manufacturing facility has now received Establishment Inspection Report classifying the manufacturing facility as ‘Voluntary Action Indicated (VAI) and that that this facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×